Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) EBITDA
Medtronic PLC's EBITDA for fiscal 2026 was $9.4B, up 6.88% from $8.8B in fiscal 2025. Over the twelve months to 31 July 2026 it was $9.7B. Over the past ten years it has ranged from $5.1B (fiscal 2015) to $9.4B (fiscal 2026) — the current reading is the highest in ten years. Medtronic PLC ranks 2nd of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $9.4B | 6.88% |
| FY2025 | $8.8B | 13.15% |
| FY2024 | $7.8B | (4.77%) |
| FY2023 | $8.2B | (3.29%) |
| FY2022 | $8.5B | 17.73% |
| FY2021 | $7.2B | (3.60%) |
| FY2020 | $7.5B | (16.50%) |
| FY2019 | $8.9B | (3.85%) |
| FY2018 | $9.3B | 11.86% |
| FY2017 | $8.3B | 1.10% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $2.5B | (3.71%) |
| Apr 2026 | $2.6B | 17.04% |
| Jan 2026 | $2.2B | (9.01%) |
| Oct 2025 | $2.4B | 10.90% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| ABT Abbott Laboratories compare | $10.8B |
| MDT Medtronic PLC | $9.7B |
| SYK Stryker Corporation compare | $6.8B |
| BSX Boston Scientific Corporation compare | $5.6B |
| PHG Koninklijke Philips N.V. compare | $3.4B |
| GEHC GE HealthCare Technologies Inc. compare | $3.3B |
| STE STERIS plc compare | $1.6B |
| EW Edwards Lifesciences Corporation compare | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MDT
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement